ARCHIVES

In Brief: Hammond Resigned As ACS Officer; Wykoff Slated To Direct FDA Special Populations Office

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

SWOG Trial Reports Longest Survival To Date For NSCLC

June 29, 2001

Amgen Announces Cochrane Findings: ESAs Increase Risk Of On-Study Death.

October 3, 2008

ORI Whistle-Blower Proposal Too Rigid, Biologists Say.

February 2, 2001

Herceptin Lowers Recurrence In Early Breast Cancer

November 25, 2005

Panel May Take On OMB In Battle to Restore NCI Construction Funds; Two Will Be Funded In FY ‘83

November 12, 1982

Nancy Brinker Resigns As CEO of Komen

August 10, 2012